| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/16/2004 | US6706495 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein |
| 03/16/2004 | US6706494 Isolated recombinant polypeptide comprising specified amino acid sequence or immunogenic fragment comprising at least 15 contiguous amino acids, which induces antibody- or t-cell mediated immune response that recognizes polypeptide |
| 03/16/2004 | US6706493 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia, parkinson's, drug addiction and eating disorders |
| 03/16/2004 | US6706491 Reagents and methods for identifying and modulating expression of genes regulated by p21 |
| 03/16/2004 | US6706488 Antigenic compound for use in the treatment,and diagnosis of cancer |
| 03/16/2004 | US6706485 Method of identifying agents that inhibit APP processing activity |
| 03/16/2004 | US6706470 Gene switches |
| 03/16/2004 | US6706312 Bioremediation of biomass impurities; wash biomass in acidic water, incubate with enzyme, filter, sterilize and concentrate biomass to powder |
| 03/16/2004 | US6706271 Cloning of BASB023 antigen from Moraxella catarrhalis |
| 03/16/2004 | US6706270 Compounds |
| 03/16/2004 | US6706269 Moraxella catarrhalis PILQ proteins |
| 03/16/2004 | US6706268 Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene |
| 03/16/2004 | US6706266 Oncostatin M antagonists |
| 03/16/2004 | US6706262 Compounds and methods for therapy and diagnosis of lung cancer |
| 03/16/2004 | CA2262500C Measles virus mutant antigen and gene coding for the same |
| 03/16/2004 | CA2234204C Novel antibody, renin-active substance containing the same and prorenin assay reagent using the same |
| 03/16/2004 | CA2223745C Method of solubilizing, purifying, and refolding protein |
| 03/16/2004 | CA2136961C Bnp antibody and immunoassay using it |
| 03/16/2004 | CA2122837C Method for refolding igf-1 to active conformation |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/12/2004 | CA2402963A1 Receptor |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004020669A1 Method of using nrse and nrsf |
| 03/11/2004 | WO2004020665A2 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 03/11/2004 | WO2004020658A1 Diagnosis of shwachman-diamond syndrome |
| 03/11/2004 | WO2004020640A2 Zinc-regulated prokaryotic expression cassettes |
| 03/11/2004 | WO2004020636A1 Nucleotide sequences encoding cry1bb proteins for enhanced expression in plants |
| 03/11/2004 | WO2004020634A1 Mutant forms of meningococcal adp-ribosylating toxin |
| 03/11/2004 | WO2004020632A1 Method for the detection of genes specifying allergen |
| 03/11/2004 | WO2004020624A1 Cancer antigens and utilization thereof |
| 03/11/2004 | WO2004020615A1 Method for the production of virus-analog particles for packing biologically active macromolecule by in vitro assembly of capsomers to which the macromolecules are bound |
| 03/11/2004 | WO2004020610A2 Methods and compositions for modulating xbp-1 activity |
| 03/11/2004 | WO2004020609A2 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
| 03/11/2004 | WO2004020608A2 Modulators of tnf-alpha and il-1 cell surface receptor activity |
| 03/11/2004 | WO2004020607A2 SPAN-Xb GENE AND PROTEIN FOR THE DIAGNOSIS AND TREATMENT OF CANCER |
| 03/11/2004 | WO2004020606A2 Method of resisting osteoclast formation |
| 03/11/2004 | WO2004020600A2 Modified aav |
| 03/11/2004 | WO2004020599A2 Hedgehog antagonists, methods and uses related thereto |
| 03/11/2004 | WO2004020598A2 Abiz phage resistance gene |
| 03/11/2004 | WO2004020596A2 Polypeptides for increasing mutant cftr channel activity |
| 03/11/2004 | WO2004020595A2 Novel human polypeptides encoded by polynucleotides |
| 03/11/2004 | WO2004020594A2 Solanum bulbocastanum late blight resistance gene and use thereof |
| 03/11/2004 | WO2004020593A2 Immune response associated proteins |
| 03/11/2004 | WO2004020591A2 Methods of use for novel human polypeptides encoded by polynucleotides |
| 03/11/2004 | WO2004020589A2 The gene for a dof transcription factor capable of altering the size and stature of a plant |
| 03/11/2004 | WO2004020588A2 Transferrin fusion protein libraries |
| 03/11/2004 | WO2004020586A2 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation |
| 03/11/2004 | WO2004020583A2 Polynucleotide predictor set for identifying protein tyrosine kinase modulators |
| 03/11/2004 | WO2004020582A2 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes |
| 03/11/2004 | WO2004020581A2 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes |
| 03/11/2004 | WO2004020578A2 Glycosylation modified il-20 |
| 03/11/2004 | WO2004020576A2 Glycosylated human granulocyte colony-stimulating factor (g-csf) isoform |
| 03/11/2004 | WO2004020471A1 Recombinant protein for preventing human chlamydia trachomatis and the uses thereof |
| 03/11/2004 | WO2004020470A1 Process for producing collagen treated with cysteine protease and collagen treated with cysteine protease |
| 03/11/2004 | WO2004020468A2 Interferon beta-like molecules for treatment of cancer |
| 03/11/2004 | WO2004020467A2 Novel mucin binding polypeptides derived from lactobacillus johnsonii |
| 03/11/2004 | WO2004020466A1 Protein tyrosine phosphatase inhibitors |
| 03/11/2004 | WO2004020465A2 Proteins involved in the regulation of energy homeostasis |
| 03/11/2004 | WO2004020464A2 Peptides able to switch between two structural states and their use |
| 03/11/2004 | WO2004020463A2 Mutant protein and refolding method |
| 03/11/2004 | WO2004020459A2 Secreted proteins |
| 03/11/2004 | WO2004020457A2 Methods and compositions for the inhibition of dna repair protein xrcc-3 |
| 03/11/2004 | WO2004020454A2 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 03/11/2004 | WO2004020452A2 Method for refolding neisserial nspa protein |
| 03/11/2004 | WO2004020405A2 Modified transferrin fusion proteins |
| 03/11/2004 | WO2004020404A2 Modified transferin-antibody fusion proteins |
| 03/11/2004 | WO2004019978A1 Recombinant nucleic acid useful for inducing protective immune response against allergens |
| 03/11/2004 | WO2004019976A2 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 03/11/2004 | WO2004019974A2 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 03/11/2004 | WO2004019971A1 Antiallergic agent |
| 03/11/2004 | WO2004019969A1 The synergistic effect of the osteogenic growth peptide and the granulocyte colony stimulating factor on haematogenesis |
| 03/11/2004 | WO2004019968A1 Methods for preserving organs and tissues |
| 03/11/2004 | WO2004019967A1 Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 03/11/2004 | WO2004019921A2 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 03/11/2004 | WO2004019893A2 Modulators of angiogenesis |
| 03/11/2004 | WO2004019883A2 Tick polypeptides as anticoagulants and vaccines |
| 03/11/2004 | WO2004019880A2 Aw755252-interacting proteins and use thereof |
| 03/11/2004 | WO2004019872A2 Oral delivery of modified transferrin fusion proteins |
| 03/11/2004 | WO2004019857A2 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
| 03/11/2004 | WO2004019856A2 Glycosylated human interferon alpha isoform |
| 03/11/2004 | WO2004007544A3 Components of the presenilin-complex |
| 03/11/2004 | WO2004007537A3 Modified adenoviral fiber with ablated to cellular receptors |
| 03/11/2004 | WO2004007525A3 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 03/11/2004 | WO2004000882A3 Proteins |
| 03/11/2004 | WO2003104489A3 Mchr1 variant associated with human obesity |
| 03/11/2004 | WO2003099862A8 Export and modification of (poly)peptides in the lantibiotic way |
| 03/11/2004 | WO2003097873A3 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications |
| 03/11/2004 | WO2003097684A3 Card-4 molecules and uses thereof |
| 03/11/2004 | WO2003095607A3 Role of p62 in aging-related disease |
| 03/11/2004 | WO2003095480A3 Brachyspira hyodysenteriae vaccine |
| 03/11/2004 | WO2003089615A3 Antiviral inhibitions of capsid proteins |
| 03/11/2004 | WO2003086308A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/11/2004 | WO2003082904A3 Modified aequorins having enhanced glowing kinetics and methods of using same |
| 03/11/2004 | WO2003078637A3 Optimizing glycan processing in plants |
| 03/11/2004 | WO2003078566A3 Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof |
| 03/11/2004 | WO2003071860A3 Method for generating maize plants with an increased leaf starch content, and their use for making maize silage |
| 03/11/2004 | WO2003071268A3 Method for discovering pharmacologically active substances |
| 03/11/2004 | WO2003068933A3 Optimization of gene sequences of virus-like particles for expression in insect cells |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003060135A3 Use of a wdv promoter for phloem-specific expression |